News

bitop AG appoints new CEO

Dortmund, June 2018: bitop is pleased to welcome its new CEO Claus Kjærsgaard (52).Claus took over the management of the biotechnology company as of June 6th, 2018.

He has a wide international range of experiences in the health care and consumer goods industry, among others with the British multinational GSK and Norwegian Pronova Biopharma SA. In the past two years Claus was CEO of Oslo based Smartfish SA.

With Claus, bitop is looking forward to continue, strengthen and expand its partnerships and businesses.
Claus replaces CEO Daniel J. Berger who will continue to serve as Member of the Executive Board. Dr. Andreas Bilstein continues to serve as CSO and Member of the Executive Board.


New study in Oncology Supportive Care published:
Patients prefer Ectoin® Mouth Wash over standard treatment (Caphosol®)

Dortmund/ Hungary, 07.06.2018: bitop is proud to announce that another successful observational study has been conducted with one of its Ectoin®-containing products. The recently published study compared Ectoin® Mouth Wash with the standard-of-care calcium phosphate mouthwash Caphosol® for the treatment of chemotherapy-induced oral mucositis. 80 % of patients using Ectoin® Mouth Wash were entirely symptom-free after 3 weeks of treatment, compared to only 43 % in the Caphosol® group. Moreover, Patients preferred Ectoin® Mouth Wash over calcium phosphate mouthwash. The study shows that Ectoin® Mouth Wash is tolerable and effective for the treatment of mucositis.

Dr. Zoltán Baráth, Pulmologist at National Korányi Institute of TBC and Pulmology in Budapest worked on the study and states:
“We are very proud that we can now offer cancer patients an innovative and effective treatment for oral mucositis whose efficacy proved to go even beyond the efficacy of the well-known standard treatment Caphosol®. Taken preventively, we might even protect patients against this painful condition. We are sure that, with Ectoin® Mouth Wash, we can make life more worth living for cancer patients.”

Here you can download the research paper and the study factsheet.

If you are interested in in-licensing one of bitop's products, please contact us: bd@bitop.de


Bayer launched Allergy Eye Drops with Ectoin®

Dortmund/ Canada, 30.05.2018: Since march, also Canadians can benefit from the soothing effects of Ectoin® in the case of allergic eye irritation. Bayer Canada launched hydraSense® Drops - Allergy Therapy. The innovative formulation with Ectoin® and hyaluronic acid lubricates, hydrates and protects the eyes. The clinically proven, naturally-sourced ingredient Ectoin® helps to relieve itchy, watery eyes and burning sensation due to allergies. Like all Ectoin® containing eye drops, the product is preservative-free and can be used with contact lenses.

bitop’s Ectoin® Allergy Eye Drops have been clinically proven to show significant reduction of local symptoms during allergic conjunctivitis. They have been tested against standard OTC drugs and placebo and show comparable efficacy as Azelastine and Ketotifen-containing eye drops. The excellent tolerability in children and adults completes the superiority of Ectoin®. Click here to read more about bitop’s Ectoin® Allergy products.

If you are interested in in-licensing one of bitop's products, please contact us: bd@bitop.de



bitop will present its latest innovations at the Vitafoods 2018 in Geneva

Dortmund, 03.05.2018: The original manufacturer of Ectoin® and Glycoin® natural will present its brand-new innovations on the Vitafoods 2018. Visit the bitop booth T-142 to get an exclusive sneak peek into the product developments and innovation pipeline. This year, Pulmonology, Ophthalmology and Animal Health are in the focus.

The SoftBreezer® combines the power of bitops Ectoin® Inhalation Solution with the device know-how of Ursatec. The portable inhaler will be released soon with a randomized clinical trial studying air pollution-induced lung disease.

The Ophthalmology line will be upgraded by the Ectoin® Eye Spray on the basis of colloids. This worldwide innovation uses colloids as a carrier system for the substance Ectoin®. A clinical trial is currently running to prove the superiority of Ectoin® Eye Spray over the German market leader.

bitop is pleased to present its Animal Health and Care portfolio that consists of two new product lines: Ectoin® pet and Ectoin® equi. The ranges have been specifically developed for man´s best friends: dogs, cats, small pets as well as horses, ponies and donkeys. All products are developed in Germany and manufactured in accordance with highest quality standards, following ISO13485.

Interested parties will get the chance to inform themselves about those pioneer products and the opportunity to get the distribution license in every country worldwide. Contact us to arrange a meeting or just come by our booth.


New USA Patent in force for the use of Glycoin® natural

Dortmund, 07.03.2018: The protection of its intellectual property is one of the main factors for the success of bitop’s Extremolytes “Made in Germany”. Therefore, the company is proud to announce that the United States of America granted another patent. Years of research have gone into the “Use of Glucosylglycerol” which is now protected in the USA. Glucosylglycerol is the chemical name for our one-of-a-kind Extremolyte Glycoin ® natural. It can be found in the resurrection plant Myrothamnus flabellifolia in the desert of South Africa. The Extremolyte protects this unique plant during drought periods from death through dehydration. This protective characteristic can be transferred to human skin where the multifunctional anti-aging and cell-boosting active ingredient targets tired, stressed or mature skin. The natural stress protection molecule revitalizes, stimulates and improves slowed or impaired cell functions to re-activate the power and appearance of youthful skin.

Abstract from the patent:

The invention relates to the use of glucosylglycerol or its esters with a view to increasing the expression of cell protective enzymes for the protection and stabilization of human skin and/or mucous membranes. It has been demonstrated that glucosylglycerol plays an effective role in the stimulation and activation of cell protective enzymes. It is thus possible in this manner to protect human skin cells effectively against damaging external influences.

If you are interested in our white label cosmetics with Glycoin® natural, or in purchasing our Extremolytes as raw material for your own cosmetic products, please contact the business development team: bd@bitop.de


bitop has moved to brand-new office building and production facility

Dortmund, 21.02.2018 : Hello Dortmund! Goodbye Witten. We have arrived in our new office building and production facility located at the “PHOENIX West” area - an innovative technology and service location in Dortmund.

With a 1.520 m² state-of-the-art production hall and 1.250 m² office and laboratory space, bitop will be able to significantly expand its production capacity for Ectoin® and other extremolytes.

From now on, our office address is:

bitop AG
Carlo-Schmid-Allee 5
44263 Dortmund, Germany
Phone: +49 231 98 77 44 0
Email: info@bitop.de


Please note that the old company address is still active and valid for R&D and manufacturing:
Stockumer Straße 28, 58453 Witten/Germany


bitop AG receives EFRE.NRW funding for investment in efficient production technology

Witten, 23.11.2017 - In the course of the move to its new company site, bitop builds a brand-new plant for the biotechnological production of high-quality protective substances. These extremolytes (e.g. Ectoin®) are manufactured for the use in medical devices, cosmetics and animal health products. A major focus in the development of the plant laid in the search for alternative production technologies and the improvement of its efficiency regarding resources and energy consumption.

“We are proud and feel honored to receive the funding. Ever since our founding, bitop stands for innovation and well-being. We aim to follow these values in every aspect of our business and are glad to do our part to protect the environment” states Daniel J. Berger, CEO.

A substantial efficiency-improvement has been reached along the complete production process from the concentration and purification to the raw product. The introduction of up-to-date membrane processes enables bitop to significantly reduce purification wastage, use of auxiliary materials and energy consumption. A closed process management protects operators from emission and makes air exchanges during the production redundant. Partner of bitop in the development, planning and realization of the plant is the OSMO Membrane Systems GmbH, a specialist for innovative solutions in the field of various filtration and reverse osmosis processes in the chemical industry.

The investment in innovative, resource- and energy-efficient production technology is substantially supported by grants from the state of North Rhine-Westphalia using funds from the European Regional Development Fund (EFRE) 2014 - 2020. The funding was granted by the State Office for Nature Environment and Consumer Protection North Rhine-Westphalia (LANUV). The decision to award funding by the LANUV was made in a competitive procedure; the submitted projects were assessed and selected by a panel of experts. In the systematic evaluation of potential for the improvement of resource and energy efficiency, bitop AG received valuable support from the Effizienz Agentur NRW - the competence center for resource efficiency in NRW.



Extremolyte – Seminar: successful 2nd edition in Taiwan.

Witten, 09.11.2017 - In cooperation with our Taiwanese distribution partner DKSH we hosted our second edition of Extremolytes – Seminar 2017 for our customers in Kaohsiung (6.11.17) and Taipei (7.11.17). bitop presented new study data about anti-pollution and blue light protection with our multifunctional “wow-active” Ectoin® and demonstrated the power of revitalization with energizing Glycoin® natural for mature and tired skin.

Thank you Taiwan for your hospitality and interest in our products.

We are looking forward to coming back in 2018!


Second edition of bitop`s technical customer workshop “Extremolyte's secret” in Taiwan

Witten, 25.10.2017 - In June 2017, we hosted our first customer workshop in Taipei, Taiwan in cooperation with our Taiwanese distribution partner DKSH. Due to the big success, bitop and DKSH organized two other events on November 6th and 7th in Taipei and Kaohsiung. The participants will have the chance to explore the world of extremolytes and get a deeper insight in our cosmetic active ingredients Ectoin® and Glycoin® natural.

We will present and discuss the mode of action, efficacy data, applications as well as the hot market and consumer trends “anti-pollution” and “blue light protection”. bitop will share the latest scientific findings – it will be exciting!

We are looking forward to these special events.


bitop broadens its eye care portfolio with a new Ectoin® ophthalmology range

Witten, 04.10.2017 - Besides its well-established Ectoin®-containing eye drops, bitop currently broadens its ophthalmology product range with different additional Ectoin®- and Glycoin® natural containing products. These new product developments are designed to prevent or treat ophthalmological diseases such as dry eye syndrome, allergic conjunctivitis, eczema and blepharitis and will fulfill various customer preferences with regards to application forms.

The range extension contains four innovative Ectoin® formulations for the eye:

  • Ectoin® Eye Serum for treatment of blepharitis
  • Ectoin® Lid Wipes for treatment of dry, irritated and inflamed eye-lids
  • Ectoin® Eye Spray for treatment of dry, tired, irritated and inflamed eyes
  • Ectoin® Eye Gel for treatment of dry, tired, irritated and inflamed eyes

Ectoin® based products have already proven their efficacy and excellent tolerability for application in the eye in several clinical studies and in different markets. The new products will line-up in bitop’s established Ectoin® eye product portfolio which consists of eye drops in ampoules or multi-dose units for dry or allergic eyes. Ectoin® containing products are suitable for very sensitive patients and children and do not contain preservatives, where applicable.

Contact our business development team to get to know more about the products and to discuss your license opportunities for our ophthalmology range: bd@bitop.de.

Meet us at

in-cosmetics Korea in Seoul,
13-15 June 2018

Meet us in Seoul at the in-cosmetics at Stand M10.


IFSCC congress in Munich,
18-21 September 2018

Meet us in Munich at the 30th ifscc congress at Stand E27.


CPhI worldwide in Madrid,
9-11 October 2018

Meet us at the IFEMA in Madrid at the CPhI 2018.


in-cosmetics North America in NY,
17-18 October 2018

Meet us in New York at the in-cosmetics at Stand A23.


in-cosmetics asia in Bangkok,
30 October - 01 November 2018

Meet us in Bangkok at the in-cosmetics asia at DKSH (Thailand) Ltd. booth D10


Past Fairs

Suppliers' Day in New York,
15-16 May 2018

Meet us in New York at the Suppliers' Day at Stand 109.


Vitafoods Europe in Geneva,
15-17 May 2018

Meet us in Geneva at the Vitafoods Europe at Stand T142.


in-cosmetics global in Amsterdam,
17-19 April 2018

Meet us in Amsterdam at the in-cosmetics global at Stand H335.


Personal Care and Homecare Ingredients (PCHi) in Shanghai,
19-21 March 2018

Meet us in Shanghai at the PCHi at Stand IF37.



3rd OTC Toolbox/PLG OTC Conference and Networking Event,
1-2 March 2018

Meet us in London at the OTC Conference in the Hilton London Tower Bridge.